Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eirini Lioudaki"'
Autor:
Elham Asgari, Claire C. Sharpe, Nicholas Cole, Helen Cronin, Bethia Manson, Kate Bramham, Grace Clark, Tayeba Roper, Richard Hull, Martin. Ford, Eirini Lioudaki, Marilina Antonelou, Debasish Banerjee, Nicola Kumar, Sarah Blakey, Nathan Hayes, Vinay Srinivasa, Richard Corbett, Andrew H. Frankel, Damien Ashby, Kieran McCafferty, Alexander Sarnowski, Ben Caplin, Alan D. Salama, David Makanjuola, D. B. Braide-Azikiwe
Publikováno v:
Clin J Am Soc Nephrol
BACKGROUND AND OBJECTIVES: Patients receiving in-center hemodialysis treatment face unique challenges during the coronavirus disease 2019 (COVID-19) pandemic, specifically the need to attend for treatment that prevents self-isolation. Dialysis unit a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd780f6b59d7b79f332fc70834fcd4f
https://openaccess.sgul.ac.uk/id/eprint/113416/1/Caplin_et_al_cJASN_R1_clean.docx
https://openaccess.sgul.ac.uk/id/eprint/113416/1/Caplin_et_al_cJASN_R1_clean.docx
Autor:
Dimitri P. Mikhailidis, Eugene Daphnis, Konstantinos Stylianou, Ioannis Petrakis, Georgios Kokologiannakis, Andreas Passam, Eirini Lioudaki, Emmanouil Ganotakis
Publikováno v:
Nephron. 131:34-42
Background: Podocyte injury plays a crucial role in the pathogenesis and progression of diabetic nephropathy (DN). We investigated whether patients with diabetes mellitus (DM) without overt DN present podocyte markers in urine suggestive of early pod
Autor:
Emmanuel Androulakis, Eugenios Daphnis, Kostas Stylianou, Eirini Lioudaki, Martin Whyte, Emmanouil Ganotakis
Publikováno v:
Clinical pharmacology and therapeutics. 102(3)
Type 2 diabetes mellitus (T2DM) is a metabolic disease affecting an increasing percentage of general population worldwide. Patients with T2DM are frequently characterized by impaired renal function, primarily as a result of diabetic kidney injury, bu
Publikováno v:
Current pharmaceutical design. 19(27)
Microalbuminuria (MA), excessive albumin excretion in the urine, is defined in different ways. MA is more prevalent among patients with diabetes mellitus (DM) and/or hypertension and correlates with adverse renal and cardiovascular (CV) outcomes. Sev
Autor:
George Vrentzos, Helen Mavrogeni, John A. Papadakis, Eirini Lioudaki, Dimitri P. Mikhailidis, Emmanuel S. Ganotakis, Maria-Helen Zeniodi
Publikováno v:
Angiology. 63(1)
Aims: The metabolic syndrome (MetS) is associated with increased risk of cardiovascular disease (CVD) and diabetes mellitus (DM). Several definitions of MetS have been proposed. The aim of the present study was to estimate and compare the prevalence